Back
Ciena Corp. 10K Form
Buy
75
CIEN
Ciena Corp.
Last Price:
$337.35
Seasonality Move:
4.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-06-06 | 10Q | CIEN/Ciena Corp. Quarterly |
| 2024-03-07 | 10Q | CIEN/Ciena Corp. Quarterly |
| 2023-09-06 | 10Q | CIEN/Ciena Corp. Quarterly |
| 2023-06-07 | 10Q | CIEN/Ciena Corp. Quarterly |
| 2023-03-08 | 10Q | CIEN/Ciena Corp. Quarterly |
| 2022-09-07 | 10Q | CIEN/Ciena Corp. Quarterly |
Receive CIEN News And Ratings
See the #1 stock for the next 7 days that we like better than CIEN
CIEN Financial Statistics
Sales & Book Value
| Annual Sales: | $4.8B |
|---|---|
| Cash Flow: | $153.8M |
| Price / Cash Flow: | 66 |
| Annual Sales: | $19.74 |
| Price / Book: | 17.08 |
Profitability
| EPS (TTM): | 1.57490 |
|---|---|
| Net Income (TTM): | $229M |
| Gross Margin: | $1.9B |
| Return on Equity: | 8.25% |
| Return on Assets: | 3.99% |
Ciena Corp. Earnings Forecast
Key Ciena Corp. Financial Ratios
-
The Gross Profit Margin over the past 30 years for CIEN is 39.31%.
-
The Selling, General & Administrative Expenses for CIEN have been equal to 17.19% of Gross Profit Margin.
-
The Research & Development expenses have been 15.60% of Revenue.
-
The Interest Expense is 72.49% of Operating Income.
-
The Net Earning history of CIEN is 2.59% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 19 years.
Ciena Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Communications Equipment |
| Sector: | Information Technology |
| Current Symbol: | CIEN |
| CUSIP: | 171779 |
| Website: | ciena.com |
Debt
| Debt-to-Equity Ratio: | 0.57 |
|---|---|
| Current Ratio: | 2.81 |
| Quick Ratio: | 1.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 397.29 |
|---|---|
| Forward P/E Ratio: | 41.03 |
CIEN Technical Analysis vs Fundamental Analysis
Buy
75
Ciena Corp. (CIEN)
is a Buy
Is Ciena Corp. a Buy or a Sell?
-
Ciena Corp. stock is rated a BuyThe current Ciena Corp. [CIEN] share price is $337.38. The Score for CIEN is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.